Specifically, we found that healthy MSCs exposed to MM cells underwent gains (HOXA9, ACVR2A, EBF2) and losses (HOXA2, HOXA3, HOXC5) of DNA methylation in the direction of those observed for MSCs from myeloma patients (Fig. 3F). The gene discussed is HOXA2; the disease is plasma cell myeloma.